Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Commentary: risks and benefits, testing and screening, cancer, genes and dollars.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics - 1 Jan 1997

Kodish E

Abstract excerpt

Author argues that the current, restrictive policy for genetic screening for cancer risk is appropriate but that diagnostic testing decisions should not be so narrowly regulated.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Decision Making
Share to Genetic Counseling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Privacy

Share to Genetic Testing

Share to Neoplasms

Share to Risk Assessment

Share to United States

Source

Identifiers

PMID: 11066507
DOI: 10.1111/j.1748-720x.1997.tb01407.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Commentary: risks and benefits, testing and screening, cancer, genes and dollars.PMID 11066507Read ↗

Banishing biases to save lives: introducing genetic testing for familial cancers.Semantic proximity Read ↗

Cancer genetic susceptibility testing: ethical and policy implications for future research and clinical practice. Cancer Genetic Studies Consortium, National Institutes of Health.Semantic proximity Read ↗

Genetic testing for breast cancer risk, from BRCA1/2 to a seven gene panel: an ethical analysis.Semantic proximity Read ↗

Can we really afford to spend NHS cash on genetic testing for cancer?Semantic proximity Read ↗

Risk assessment for inherited susceptibility to cancer: a review of the psychosocial and ethical dimensions.Semantic proximity Read ↗

[To what extent can the publicly sponsored health system afford predictive genetic diagnostics?--first approaches to pinpoint and limit responsibilities, exemplified by hereditary carcinomas].Semantic proximity Read ↗

Cancer genetics services: a systematic review of the economic evidence and issues.Semantic proximity Read ↗

Genetic screening by DNA technology: a systematic review of health economic evidence.Semantic proximity Read ↗

Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing.Semantic proximity Read ↗

Hereditary cancer risk notification and testing: how interested is the general population?Semantic proximity Read ↗

Commentary on "Distinguishing genetic from nongenetic medical tests: some implications for antidiscrimination legislation" (J.S. Alper and J. Beckwith)Semantic proximity Read ↗

Commentary: The risk of variant Creutzfeldt-Jakob Disease: reassurance and uncertainty.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.